Next, Lanrun Pharmaceutical Factory's production lines began to be in place one after another. On average, a new production line could be assembled in about ten days. In one month, the production lines had increased from the original one to three.

In this month, Lanrun Pharmaceutical's "Fushen No. 1" has reached 12 million yuan.

Lanrun Group recently paid 100 million yuan from banks through loans, specifically to increase the production lines of pharmaceutical factories. It plans to expand the scale of pharmaceutical factories to have more than 25 production lines in the future.

If the twenty-five production lines are specifically used to produce new drug "Fushen No. 1", the monthly factory sales volume is about 150 million yuan. This scale is already very large, and it is estimated that it is more than enough to meet the market demand of the entire China.

In this way, the annual output value of the pharmaceutical factory's production of "Fushen No. 1" is 1.8 billion. After deducting related costs and employee salaries and benefits, the net profit is about 1.5 billion.

Only then can you pay off the loan of 10 billion yuan. Of course, if interest is added, it will probably take about six years.

This is already very good. At present, new drugs only occupy the number one position in the domestic psychotropic drug market and have achieved such results. If the channels are expanded overseas, I believe that Lanrun Pharmaceutical will recover faster.

The new drug has started its first shot in China, which has also allowed Qin Lang, the largest investor and shareholders of the pharmaceutical industry to see hope, and has increased its investment in laboratories. It has also allowed researchers to conduct research attempts on various new drugs with greater peace of mind, and no longer have to worry about funding and interrupt research.

The successful entry of new drugs into the market has received a good response in the market, and has also made the entire Lanrun Pharmaceutical sector become vibrant and vigorous. At present, the funds are in a virtuous cycle, and the future prospects are immeasurable.

At present, the cooperation between Qin Lang's Lanrun Pharmaceutical and Huairen Pharmaceutical Chain Group has become closer because of "Fushen No. 1", and "Fushen No. 1" is like a golden rooster that can lay eggs.

Now not only Lanrun, but also Huairen Pharmaceuticals benefit directly or indirectly, because only the chain terminals of Huairen are sold. Now the customer flow in the pharmaceutical market is beginning to enter Huairen’s storefronts with geometric numbers, which has attracted several times of popularity and a good reputation. The turnover in recent months has also increased, increasing several times.

The executive general manager of Huairen Pharmaceutical Chain Group also formed an alliance with Lanrun Pharmaceutical because of his unique vision and borrowed this lucky golden rooster from Huairen, which was unanimously praised by Huairen.

I heard that when Huairen Pharmaceutical Chain Group held a board meeting, Luo Lizhi's annual salary increased by half to 15 million due to this incident. This is indeed something to be proud of for Luo Lizhi.

For Luo Lizhi, money is actually a small matter. The key is that he has received recognition from the whole company, but the achievements and prestige he brought are of great significance.

Luo Lizhi, who was proud of himself, often talked to Qin Lang on phones. Sometimes, the two of them were no longer just a partnership in the business world, but became more and more like friends.

On this day, when Qin Lang was chatting with Luo Lizhi for a while, Luo Lizhi suddenly gave Qin Lang a message: "Enke Pharmaceutical, a partner of Huairen Pharmaceuticals, will come to China recently for inspection. Enke Pharmaceutical has sales channels in about ten countries in Europe and the United States. If Lan Run is interested, you can talk to Enke Pharmaceutical about overseas channel cooperation."

"Enke Pharmaceutical?"

After Qin Lang answered the phone, he asked the company's assistant to check out this foreign pharmaceutical industry giant. After checking, he found out that Enke Pharmaceutical started by selling condoms and has several licenses in the world for drug and health products. It has now become one of the world's top 500 companies.

However, Enko Pharmaceutical's strength ranking among overseas pharmaceutical channel vendors is not high, at most outside the 50th place.

Even so, Qin Lang was overjoyed. After all, Lanrun Pharmaceutical has just been established for a short time. Through cooperation with channel dealers like Huairen Pharmaceutical Chain Group, China has barely set off its sign and gained a foothold.

If you are abroad, Lanrun Pharmaceutical is simply blank. If you can seize the opportunity to contact Enke Pharmaceutical through this news provided by Luo Lizhi and promote the new drug "FuShen No. 1" to the overseas market through Enke Pharmaceutical's overseas sales channels, it will undoubtedly be a very wonderful thing.

In terms of things, all the senior executives of Lanrun Group have been thinking about this matter for most of the past half month, which is how to promote new drugs overseas as soon as possible.

Because of the first time I entered the new field of medicine, Lanrun Group's relationship network in the pharmaceutical field is almost the same as a piece of paper, so I have always been at a loss as to how to use it to open up overseas channels.

After that, Qin Lang kept in touch with Luo Lizhi by phone, asking Luo Lizhi to help him a little, so that he could pay attention to when Enke Pharmaceutical, a foreign pharmaceutical chaebol, would enter the Chinese market for investigation, and it would be better to find an opportunity to contact him.

Luo Lizhi is indeed a friend, so he kept paying attention to this matter afterwards. He suddenly contacted Qin Lang half a month later: "There is news that the inspection team of Enke Pharmaceutical will arrive in the Magic City in three days. At that time, several domestic pharmaceutical industry giants will hold a pharmaceutical exchange meeting to welcome this foreign pharmaceutical peer inspection team."

"The people who can join this pharmaceutical exchange meeting are all top ten companies in the Chinese pharmaceutical industry. Originally, you Lanrun Pharmaceutical is not qualified as a new company, but we Huairen Pharmaceutical is also one of the organizers of the event. You can send you an invitation letter in advance. At that time, you can enter the venue of the exchange meeting with the invitation letter."

After listening to Luo Lizhi's words, Qin Lang said gratefully: "Then please trouble Mr. Luo." Luo Lizhi is a very good person. Qin Lang's emotional investment over the past period has finally paid off. Whether he can successfully obtain overseas sales channels now can see his performance at the medical exchange meeting.

However, the new drug "Fushen No. 1" was very successful. Qin Lang had sufficient reasons to believe that the overseas inspection team of Enke Pharmaceuticals could not be unhappy in the face of such an excellent new drug.

Therefore, it is only a matter of time to use new drugs to open up the overseas market. Now, Enko Pharmaceutical is just a little bit ahead of this time.

...

Magic City, No. 1 Stadium is the meeting place for this exchange meeting.

The No. 1 Stadium is also one of the landmark buildings in the entire Magic City. It has an indoor football field that accommodates tens of thousands of fans, as well as other sports venues such as swimming pools, golf courses, badminton balls, etc.

This time the exchange meeting actually only occupied a very small piece of the venue in the gymnasium and made some arrangements. Although it was a small venue, it was actually not small, and there was absolutely no problem in accommodating two or three thousand people.

The entire venue was arranged like walking on a red carpet. This event was said to be to welcome the Enke Pharmaceutical inspection team. In fact, it is better to say that it is also a gathering of many domestic pharmaceutical industry giants. As competitors, everyone has a rare opportunity to appear together, so these pharmaceutical industry giants attach great importance to this exchange meeting.

On this day, Qin Lang also appeared at the exchange meeting with an invitation letter. In addition to Tang Qian, general manager of Lanrun Group, he also accompanied him, his girlfriend Liu Zhenzhen.

After entering the venue, Qin Lang realized that the interior of the entire exchange meeting venue was even more luxurious than a five-star hotel. The tables and chairs on the conference venue were all the most expensive mahogany, and the tables were filled with various rare fruits and drinks. In addition, dozens of oil paintings were hung on the walls around the conference venue. Qin Lang even saw a genuine work that was said to be Picasso.

Foreign representatives of the Enko delegation have not yet arrived at the exchange meeting. At present, the exchange meetings are all gathered by these medical giants in China. When Qin Lang brought people into the exchange venue, he only heard the entire venue was filled with buzzing noises of conversations between each other.

"Zhenzhen, you and Tang Qian stay here first, I'll go around first." Qin Lang said to Liu Zhenzhen.

"Okay." Liu Zhenzhen nodded, and they were both resting in a corner of the venue.

Qin Lang searched for a long time, but did not find Luo Lizhi, the general manager of Huairen Pharmaceutical Chain Group. Now many people in the entire hall seemed quite crowded. Qin Lang accidentally bumped into a guy while searching, said sorry and was ready to continue walking, but was pulled by that person.

"Wait, I know you. Aren't you the boss of the Lanrun Pharmaceutical Company that has recently emerged in China?" the man said to Qin Lang.

"Oh, may I ask you..."

Qin Lang looked up in surprise and saw a young man with a head as big as Einstein but a thin figure, who was in his twenties.

"Haha, let me introduce it. Sun Haotian, chairman of Huairen Pharmaceutical Chain Group, is my grandfather, and General Manager Luo Lizhi is my uncle... My name is Sun Jiatian, and I just came back from abroad to prepare to take over the old man's work."

The big-headed guy said with a smile.

It turned out to be the third generation of the partner Huairen Pharmaceutical Chain Group. However, although this guy was wearing a formal outfit, he was dressed very untidy. Even the buttons of the suit were wrong, and he looked oily and gas.

Out of politeness, Qin Lang stretched out his hand: "I'm very happy to know you. I'm Qin Lang from Lanrun Company."

"Hello, hello."

Seeing Qin Lang so polite, Sun Jiatian was so happy that he held Qin Lang's hand and didn't want to let go.

"Let's go with me, you don't know... I've been abroad for three years. This time I've been back in China, but I've heard a lot of news about you. Not only my grandfather and uncle praised you, but they said that the boss of our Huairen partner Lan Run is a business talent. Even some of my best friends in the circle of playmates admire you very much, because you gave Duan Feifei's cousin a lesson."

"Duan Feifei?"

Qin Lang was very confused. He had never heard of this name.

"Duan Feifei is the third son of Duan Ritian of Jindali Pharmaceutical Group. He is also very famous among our generation. He is a lawless master..."

Sun Jiatian is simply a chattering guy, and he never finished talking about it.

Qin Lang also understood at this time. It turned out that Sun Jiatian had already learned about the scum of Jin Dali's previous lesson. Because Pang Li, who had been taught a lesson by Qin Lang, was a member of Jin Dali Pharmaceutical Group, and was also the cousin of Duan Feifei, the same young master in the mouth of the stinky boy in front of him.
Chapter completed!